Related Experiment Video
Updated: Jun 12, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
Development and validation of a spectrofluorimetric method for the estimation of rivastigmine in formulations
R Kapil1, S Dhawan, Bhupinder Singh
1University Institute of Pharmaceutical Sciences (UGC Centre of Advanced Studies) Panjab University, Chandigarh-160 014, India.
Abstract:
A rapid, sensitive, simple, and cost-effective spectrofluorimetric method was developed for the estimation of rivastigmine in bulk and pharmaceutical formulations. The relative fluorescence intensity of rivastigmine was measured in triple distilled water at an excitation wavelength of 220 nm and an emission wavelength of 289 nm. Linearity range was found to be 100 to 4000 ng/ml. The method was validated for various parameters as per the ICH guidelines and USP requirements. The detection and quantitation limits were found to be 20.5 and 62.1 ng/ml, respectively. The results demonstrate that the procedure is accurate, precise, and reproducible, while being simple and rapid too. The results were found to be in good agreement with the label claims.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
In Vitro Drug Release Testing: Overview, Development and Validation
Clinically Relevant Drug Product Specifications: Methods of Establishment
In Vitro Drug Dissolution: Alternative Methods
